Traditional Chinese medicine composition for treating cerebral apoplexy
A kind of composition and technology for cerebral apoplexy, applied in the direction of drug combination, medical formula, plant raw materials, etc., can solve Shuwei's "Skillful Prescription"; Jin Dynasty Dou Hanqing's "Complete Book of Sores and Ulcers", Liu Wansu's "Hejian Six Books" Zhang Congzheng's "Confucianism" in the Yuan Dynasty, Li Gao's "Dongyuan Ten Books", Zhu Zhenheng's "Danxi Heart Method", Luo Qianfu's "Health Treasure Mirror"; , Dai Sigong's "Syndrome and Treatment Essentials", Lou Ying's "Medical Compendium", Wang Lun's "Miscellaneous Works of Ming Medicine", Li Bing's "Introduction to Medicine", Li Zhongzi's "Must Read of Medical History", Xue Ji's "Xue's Medical Cases", Fang Xian "Miraculous Prescriptions", Zhang Sanxi's "Six Essentials of Medical Principles", Tao Hua's "Six Books on Febrile Diseases", Wang Kentang's "Guidelines for Syndrome and Treatment", Chen Shigong's "Orthodox Surgery", Zhang Jiebin's "Jingyue Quanshu"; Law of the People's Republic of China, Chen Shiduo's "Secret Records of the Stone Chamber, Side Effects of Patients, Lack of Dialectical Prescriptions" and other issues, achieving the effect of remarkable and reliable curative effect, low cost, and easy preparation
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0024] A traditional Chinese medicine composition for treating cerebral apoplexy, which is prepared from the following raw materials in weight ratio:
[0025] 35 parts of ginseng, 33 parts of white lentils, 30 parts of ginkgo biloba, 25 parts of epimedium, 25 parts of forsythia,
[0026] 25 parts of Gastrodia elata, 22 parts of myrrh, 22 parts of Rehmannia glutinosa, 20 parts of Sophora japonica, 20 parts of jujube seed,
[0027] 18 parts of Fructus Aurantii, 18 parts of Calamus, 18 parts of Trichosanthes, 17 parts of Acanthopanax, 17 parts of Polygala,
[0028] 17 parts of perilla leaves, 17 parts of Chuanxiong, 17 parts of Danshen, 15 parts of radish seeds, 15 parts of Gynostemma,
[0029] 10 parts of amaranth, 10 parts of turmeric, 10 parts of angelica, 8 parts of Eucommia, 8 parts of astragalus,
[0030] Poria cocos 5 parts, Albizia juniper skin 5 parts, dandelion 5 parts.
[0031] Its preparation method of the pharmaceutical composition of the present invention is: tak...
Embodiment 2
[0039] zoology experiment
[0040]40 healthy Kunming mice, half male and half female, weighing 18.5±2.0g, were randomly divided into two groups, 20 of which were used as the control group and fed with normal water; the other 20 The mice were given the medicine of Example 1, and the acute toxicity experiment was carried out in mice to show that: compared with the matched group, the mice had no significant difference after administration, and the experiment was observed continuously for two weeks. normal. On the day of administration and within two weeks after administration, no animal died, suggesting that the drug has low acute toxicity and is safe for clinical use.
[0041] long-term toxicity test
[0042] Select 40 SD rats, half male and half male. According to body weight, be divided into 2 groups at random, i.e. control group (giving equal amount of distilled water), Chinese medicine group of the present invention. 20 in each group, half male and half male. Animals in...
Embodiment 3
[0044] clinical case
[0045] Randomly select 100 patients with cerebral apoplexy admitted to the hospital for treatment, who meet the diagnostic criteria of cerebral apoplexy, all of whom have the first onset, and receive treatment 6 hours after the onset. The patients were randomly divided into two groups. The treatment group consisted of 50 cases, including 26 males and 24 females, aged 41-77 years, with an average neurological deficit score of 25.03±5.65. The control group consisted of 50 cases, including 25 males and 25 females, aged 42-78 years, with an average neurological deficit score of 25.40±6.33. There was no significant difference in the age of onset, gender and neurological impairment score among the groups (P>0.05).
[0046] Inclusion criteria The selected patients are all acute stroke patients, all confirmed by head CT or MRI examination, in line with the diagnostic criteria for stroke formulated by the Fourth National Cerebrovascular Disease Conference, and d...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com